F. Finlayson

CNS imaging studies in cystic fibrosis patients presenting with sudden neurological events

T. Kotsimbos, S. Ellis, D. Thyagarajan, 2019, BMJ Open Respiratory Research.

Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis

T. Kotsimbos, B. Button, E. Paul, 2020, ERJ Open Research.

End of life care in CF: patients, families and staff experiences and unmet needs.

T. Kotsimbos, John W. Wilson, M. Gold, 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Distal intestinal obstruction syndrome in cystic fibrosis: presentation, outcome and management in a tertiary hospital (2007–2012)

T. Kotsimbos, S. Warrier, R. Subhi, 2014, ANZ journal of surgery.

The AWESCORE, a patient-reported outcome measure: development, feasibility, reliability, validity and responsiveness for adults with cystic fibrosis

T. Kotsimbos, A. Tierney, B. Button, 2021, ERJ Open Research.

Adverse events arising from a palliative care survey

T. Kotsimbos, M. Gold, J. Philip, 2009, Palliative medicine.

End-of-life care in adults with cystic fibrosis.

T. Kotsimbos, Jane Harris, M. Gold, 2008, Journal of palliative medicine.

ePS03.4 Patient reported adherence to ivacaftor

T. Kotsimbos, A. Tierney, B. Button, 2015 .

ePS05.3 Ivacaftor and its effects on body composition in adults with G551D related cystic fibrosis

T. Kotsimbos, A. Tierney, B. Button, 2015 .

WS09.5 Effect of ivacaftor on wellness, quality of life and cognitive function in adults with cystic fibrosis and G551D mutation

T. Kotsimbos, A. Tierney, B. Button, 2015 .

73 The effect of ivacaftor CFTR gene-potentiating therapy on cytokine levels in CF patients with the G551D mutation

T. Kotsimbos, N. Mifsud, John W. Wilson, 2017 .